APA (7th ed.) Citation

Leman, R., Cherifi, F., Leheurteur, M., Theret, P., Pasquesoone, C., Saint-Ghislain, M., . . . Deruche, E. (2025). Homologous recombination deficiency (HRD) tests for ovarian cancer: A multicenter French phase II study (HERO). BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14423-2

Chicago Style (17th ed.) Citation

Leman, Raphaël, et al. "Homologous Recombination Deficiency (HRD) Tests for Ovarian Cancer: A Multicenter French Phase II Study (HERO)." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14423-2.

MLA (9th ed.) Citation

Leman, Raphaël, et al. "Homologous Recombination Deficiency (HRD) Tests for Ovarian Cancer: A Multicenter French Phase II Study (HERO)." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14423-2.